Henry Schein, Inc. $HSIC Shares Bought by Jones Financial Companies Lllp

Key Points

• Jones Financial Companies Lllp significantly increased its stake in Henry Schein, Inc. by 24,351.3%, acquiring 540,112 shares during the first quarter, bringing its total ownership to 542,330 shares valued at approximately $37.14 million.
• Several institutional investors, including Steadfast Capital Management and Millennium Management, also made substantial investments in Henry Schein, revealing strong interest from hedge funds with 96.62% of the stock held by institutions.
• Analysts have mixed ratings for Henry Schein, with price targets ranging from $75.00 to $83.00, reflecting cautious optimism about the company's future performance despite a recent earnings miss.

Jones Financial Companies Lllp increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 24,351.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 542,330 shares of the company's stock after buying an additional 540,112 shares during the quarter. Jones Financial Companies Lllp owned about 0.45% of Henry Schein worth $37,144,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Investment Management Corp VA ADV purchased a new stake in Henry Schein in the 4th quarter valued at approximately $32,000. Rakuten Securities Inc. purchased a new stake in Henry Schein in the 1st quarter valued at approximately $34,000. Whittier Trust Co. boosted its holdings in Henry Schein by 714.3% in the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after purchasing an additional 700 shares in the last quarter. Quarry LP purchased a new stake in Henry Schein in the 1st quarter valued at approximately $71,000. Finally, UMB Bank n.a. boosted its holdings in Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after purchasing an additional 201 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Price Performance

HSIC stock traded down $0.54 on Friday, reaching $69.01. The company had a trading volume of 1,115,039 shares, compared to its average volume of 1,429,852. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The company's fifty day moving average is $69.32 and its 200 day moving average is $69.46. The company has a market cap of $8.37 billion, a P/E ratio of 22.26, a PEG ratio of 2.29 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. During the same period in the previous year, the company posted $1.23 EPS. Henry Schein's quarterly revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on HSIC shares. Robert W. Baird reaffirmed a "neutral" rating and issued a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a report on Sunday, September 7th. Baird R W lowered Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday, July 14th. Stifel Nicolaus reaffirmed a "hold" rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Finally, JPMorgan Chase & Co. decreased their price target on Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Five investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $76.67.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.